91人人澡人人妻人人澡-日韩午夜在线观看视频-亚洲一区二区三区欧美激情-日韩精品在线观看视频

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

日韩一区二区三区久久| 东京热男人的天堂社区| 国产精品福利精品福利| 国产欧美日韩视频91| 欧美日韩一级aa大片| 午夜国产成人福利视频| 欧美自拍系列精品在线| 欧美黑人在线一区二区| 欧美中文字幕日韩精品| 日韩人妻毛片中文字幕| 国产精品99一区二区三区| 国产成人人人97超碰熟女| 日韩精品人妻少妇一区二区| 欧美一区二区三区性视频| 深夜福利欲求不满的人妻| 白白操白白在线免费观看| 91欧美视频在线观看免费| 深夜福利亚洲高清性感| 正在播放国产又粗又长| 久久老熟女一区二区三区福利| 国产精品午夜视频免费观看| 扒开腿狂躁女人爽出白浆av| 精品一区二区三区乱码中文| 亚洲中文字幕熟女丝袜久久| 激情综合五月开心久久| 亚洲欧美黑人一区二区 | 激情综合五月开心久久| 观看日韩精品在线视频| 中文字幕五月婷婷免费| 国产成人综合亚洲欧美日韩| 精品一区二区三区中文字幕| 日本午夜免费观看视频| 成人国产一区二区三区精品麻豆| 亚洲高清中文字幕一区二三区| 免费大片黄在线观看日本| 视频在线免费观看你懂的| 香蕉网尹人综合在线观看| 国产日本欧美特黄在线观看| 国产激情一区二区三区不卡| 国内欲色一区二区三区| 国产精品白丝久久av|